About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Houston | 22,488 Studies Near You

Clinical TrialsHouston

Clinical Trials in Houston

Discover 22,488 clinical trials near Houston, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4601-4620 of 22,488 trials

RecruitingA Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 AlterationsPhase 1 will evaluate the safety and tolerability at different dose levels of repotrectinib in pediatric and young adult subjects with advanced or metastatic malignancies…NCT04094610·Los Angeles, California and 67 others

Find Trials by Condition in Houston

Breast Cancerin Houston Lung Cancerin Houston Prostate Cancerin Houston Colorectal Cancerin Houston Melanomain Houston Leukemiain Houston Lymphomain Houston Pancreatic Cancerin Houston Ovarian Cancerin Houston Brain Cancerin Houston Diabetes

Data from ClinicalTrials.govTerms

Not yet recruitingA Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain ManagementThe purpose of this study is to evaluate if it is possible to use intravaginal high-density surface electromyography to guide Botulinum neurotoxin (BoNT) injection to treat pelvic…NCT05062902·Houston, Texas

Enrolling by invitationAn Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007This is a multiregional open-label extension (OLE) to assess the safety, tolerability, and efficacy of long-term treatment with tividenofusp alfa (DNL310), an investigational…NCT06075537·Oakland, California and 29 others

TerminatedChemoradiation Plus Durvalumab Followed by Surgery Followed by Adjuvant Durvalumab in Patients With Surgically Resectable Stage III (N2) Non-Small Cell Lung CancerThis is an open label, multi-institutional, single arm Phase II trial. All patients will be treated with Carboplatin, Paclitaxel, Durvalumab and Radiation.NCT03871153·Chicago, Illinois and 3 others

TerminatedOpen-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesThe purpose of the Study is to select a dose and assess the safety and tolerability of INCB057643 as a monotherapy (Part 1 and Part 2) and in combination with standard-of-care…NCT02711137·Birmingham, Alabama and 17 others

CompletedPhase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of PrematurityThe purpose of this study is to find a dose of intravitreal bevacizumab that is lower than currently used for severe retinopathy of prematurity (ROP), is effective in this study…NCT02390531·Atlanta, Georgia and 10 others

Active not recruiting(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic MastocytosisThis is a multi-part, randomized, double-blind, placebo-controlled Phase 2 clinical study comparing the safety and efficacy of bezuclastinib (CGT9486) plus best supportive care…NCT05186753·Birmingham, Alabama and 56 others

CompletedTH9507 in Patients With HIV-Associated LipodystrophyHIV lipodystrophy affects a significant proportion of patients treated with combination antiretroviral therapy (ART) and is characterized by excess visceral fat accumulation and…NCT00123253·Los Angeles, California and 41 others

CompletedStudy to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple SclerosisThis is a randomized, double-blind study of PIPE-307 or placebo in subjects with relapsing-remitting multiple sclerosis.NCT06083753·Phoenix, Arizona and 20 others

CompletedMesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With MalignanciesThe goal of this clinical research study is to learn about the safety of giving mesenchymal stem cells (MSCs) to patients who have ARDS.NCT02804945·Houston, Texas

CompletedTalazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast CancerThis phase II trial studies the side effects of talazoparib when given before standard therapy in treating patients with breast cancer that has spread to nearby healthy tissue and…NCT02282345·Houston, Texas

CompletedTrial to Evaluate Efficacy and Safety of Lenabasum in Cystic FibrosisThis is a Phase 2 multicenter, double-blind, randomized, placebo-controlled study assessing the efficacy and safety of lenabasum for the treatment of cystic fibrosis in patients…NCT03451045·Phoenix, Arizona and 104 others

TerminatedPhase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/TranslocationsInfigratinib is an oral drug which selectively binds to fibroblast growth factor receptor (FGFR) 2 and is being developed to treat participants with FGFR2 mutated…NCT03773302·Gilbert, Arizona and 115 others

CompletedA Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)This research study will examine the safety and effectiveness of ONS-5010 in participants with AMD.NCT03834753·Tucson, Arizona and 49 others

TerminatedG-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)This is a long-term safety follow-up study to assess the post-treatment safety, at 12 and 24 months, in patients with type 2 diabetes after participation in the phaseII/III…NCT00255645·Birmingham, Alabama and 542 others

TerminatedDocetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004037·Birmingham, Alabama and 66 others

CompletedDevice to Reduce Surgery Site ContaminationThe objective of this study is to determine whether the Air Barrier System device reduces airborne particulate and airborne colony forming units present at a surgery site.NCT00972153·Houston, Texas

Active not recruitingPressure Enabled Intrapancreatic Delivery of SD-101 With Checkpoint Blockade for Locally Advanced Pancreatic AdenocarcinomaThis study is an open-label, phase 1/1b study of the pressure-enabled intrapancreatic infusion of SD-101, a TLR 9 agonist, alone or in combination with intravenous checkpoint…NCT05607953·Houston, Texas

Active not recruitingEffect of Pulmonary Rehabilitation on Surgical Outcomes in the Cancer SettingThe goal of this clinical research study is to see if pulmonary rehabilitation can improve patients' lung function, which would increase their chances of becoming eligible for…NCT00618553·Houston, Texas

CompletedIncontinent Urinary Diversion Using an Autologous Neo-Urinary ConduitThe purpose of this study is to see if the Neo-Urinary Conduit(NUC), which is made in the laboratory from a combination of a patient's own cells and other materials can be used to…NCT01087697·Chicago, Illinois and 5 others

PreviousPage 231 of 1125Next

in Houston

Heart Diseasein Houston